- Home
- LFCR vs JRI Comparison
LFCR vs JRI Comparison
Compare LFCR & JRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFCR
- JRI
- Stock Information
- Founded
- LFCR 1986
- JRI 2012
- Country
- LFCR United States
- JRI United States
- Employees
- LFCR N/A
- JRI N/A
- Industry
- LFCR Biotechnology: Pharmaceutical Preparations
- JRI Finance Companies
- Sector
- LFCR Health Care
- JRI Finance
- Exchange
- LFCR Nasdaq
- JRI Nasdaq
- Market Cap
- LFCR 308.8M
- JRI 367.7M
- IPO Year
- LFCR N/A
- JRI N/A
- Fundamental
- Price
- LFCR $7.21
- JRI $13.76
- Analyst Decision
- LFCR Buy
- JRI
- Analyst Count
- LFCR 4
- JRI 0
- Target Price
- LFCR $8.00
- JRI N/A
- AVG Volume (30 Days)
- LFCR 110.8K
- JRI 68.0K
- Earning Date
- LFCR 10-03-2025
- JRI 01-01-0001
- Dividend Yield
- LFCR N/A
- JRI 9.38%
- EPS Growth
- LFCR N/A
- JRI N/A
- EPS
- LFCR N/A
- JRI N/A
- Revenue
- LFCR $128,867,000.00
- JRI N/A
- Revenue This Year
- LFCR $4.78
- JRI N/A
- Revenue Next Year
- LFCR $12.02
- JRI N/A
- P/E Ratio
- LFCR N/A
- JRI N/A
- Revenue Growth
- LFCR 0.47
- JRI N/A
- 52 Week Low
- LFCR $4.33
- JRI $9.70
- 52 Week High
- LFCR $8.85
- JRI $12.12
- Technical
- Relative Strength Index (RSI)
- LFCR 43.53
- JRI 71.02
- Support Level
- LFCR $7.37
- JRI $13.27
- Resistance Level
- LFCR $8.69
- JRI $13.60
- Average True Range (ATR)
- LFCR 0.36
- JRI 0.11
- MACD
- LFCR -0.02
- JRI 0.03
- Stochastic Oscillator
- LFCR 11.38
- JRI 95.12
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.
About JRI Nuveen Real Asset Income and Growth Fund of Beneficial Interest
Nuveen Real Asset Income and Growth Fund is the United States-based closed-end fund. Its objective is to provide a high level of current income and long-term capital appreciation. The fund invests a majority of its managed assets in equity and debt securities issued by real asset related companies located anywhere in the world. Its plan involves investments in five security types, infrastructure common stock, REIT preferred stock and debt securities. Real asset-related companies include those engaged in owning, operating, or developing infrastructure projects, facilities, and services, as well as REITs.